These findings indicate that miR-9 upregulation was associated with a malignant phenotype of bladder cancer and promoted cell proliferation and chemoresistance by targeting LASS2 in bladder cancer [94]. This evidence concerns the gene CERS2 and urinary bladder carcinoma.